Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma
Yajie Zhou, Zijian Hu, Lei Xie, Shuwen Zhang, Qi Huang, Nan Zhang, Yijiang Liu, Wenxiong Zhang, Kang Wang · 2026
Read Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma by Yajie Zhou, Zijian Hu, Lei Xie, Shuwen Zhang, Qi Huang, Nan Zhang, Yijiang Liu, Wenxiong Zhang, Kang Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13457836.txt.
Description
Yajie Zhou and colleagues built a prognostic score for clear cell kidney cancer from genes related to bone morphogenetic proteins, growth signals that guide cell identity. Their 2026 study combined tumor gene data with patient records to find which of these messages best predicted survival. The search produced a nine-gene signature, including L1CAM, CLIC5, PLG, and CA8, that split patients into high-risk and low-risk groups with clearly different outcomes.
Patients in the high-risk group survived significantly less time, and a combined chart adding the score to standard clinical factors predicted outcomes with an accuracy measure of 0.747 on the usual curve scale. High-risk tumors also carried more mutations overall and showed immune patterns dominated by antibody-producing cells. Drug-sensitivity profiling suggested the two groups respond differently to specific compounds.
Catalog record
| CREATOR | Yajie Zhou, Zijian Hu, Lei Xie, Shuwen Zhang, Qi Huang, Nan Zhang, Yijiang Liu, Wenxiong Zhang, Kang Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |